HCF, the oldest of the “Big Four” Australian health funds, has bought a 15% stake in telemedicine online doctor service startup GP2U. [grow_thumb image=”https://telecareaware.com/wp-content/uploads/2016/01/HCF-logo.jpg” thumb_width=”150″ /]GP2U provide systems which helps to make remote consultations via video conferencing possible.
According to yesterday’s press release HCF will run a pilot to “ensure the service is scaled to the wider HCF membership as smoothly as possible”. In addition to providing the video conferencing platform, [grow_thumb image=”https://telecareaware.com/wp-content/uploads/2016/01/GP2U-logo.png” thumb_width=”150″ /]GP2U also provides a prescription service that sends prescriptions directly from the GP office to pharmacy once the GP approves it. GP2U has agreements with three Australian pharmacy chains, Terry White Chemist, Chempro and Priceline.
HCF is a not-for-profit organisation founded 80 years ago and provides health cover for 1.5 million Australians and has a turnover in excess of AUD 2 billion. GP2U is very fortunate that such a large fund has taken a serious interest in it